|
" Alkaloids : "
Eduardo Sobarzo-Sánchez
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
762846
|
| Doc. No
|
:
|
b582825
|
| Main Entry
|
:
|
Eduardo Sobarzo-Sánchez
|
| Title & Author
|
:
|
Alkaloids : : Biosynthesis, Biological Roles and Health Benefits.\ Eduardo Sobarzo-Sánchez
|
| Publication Statement
|
:
|
Hauppauge : Nova Science Publishers, Inc., 2015
|
| Series Statement
|
:
|
Biochemistry research trends series.
|
| Page. NO
|
:
|
(285 pages).
|
| ISBN
|
:
|
1634820754
|
|
|
:
|
: 9781634820752
|
| Notes
|
:
|
COMPLETED AND ONGOING CLINICAL TRIALS.
|
| Contents
|
:
|
ALKALOIDS: BIOSYNTHESIS, BIOLOGICAL ROLES AND HEALTH BENEFITS; ALKALOIDS: BIOSYNTHESIS, BIOLOGICAL ROLES AND HEALTH BENEFITS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: TARGETING MITOCHONDRIAL BIOENERGETICS OFCANCER CELLS WITH ALKALOIDS: MECHANISMSAND ANTI-CANCER STRATEGIES; ABSTRACT; I. INTRODUCTION: ALKALOIDS ACTING ON MITOCHONDRIAOF CANCER CELLS; II. MITOCHONDRIAL BIOENERGETICS AS TARGET FORANTI-CANCER ALKALOIDS; III. INDUCTION OF MITOCHONDRIA -MEDIATED CELL DEATHBY ANTI-CANCER ALKALOIDS. IV. ALKALOIDS WITH CLINICAL USES THAT AFFECTMITOCHONDRIA OF CANCER CELLSCONCLUSION; ACKNOWLEDGMENT; REFERENCES; Chapter 2: BOLDINE AS ANTIOXIDANT: FROM FARM TO PHARMACY; ABSTRACT; INTRODUCTION; BOLDO AS A MEDICINAL PLANT; BOLDO IN TRADITIONAL MEDICINE; CULTIVATION OF BOLDO; BOLDINE, ONE OF THE MAIN CONSTITUENTS OF BOLDO; TOXICITY OF BOLDINE; BOLDINE AS ANTIOXIDANT; STRUCTURE ACTIVITY RELATIONSHIP; CONCLUSION AND FUTURE PROSPECTS; REFERENCES; Chapter 3: BIOSYNTHESIS OF AMARYLLIDACEAE ALKALOIDS:A BIOCHEMICAL OUTLOOK; ABSTRACT; INTRODUCTION; BIOSYNTHESIS. METABOLIC ENGINEERING AND SYNTHETIC BIOLOGYCONCLUSION; REFERENCES; Chapter 4: MARINE BROMINATED ALKALOIDS:ISOLATION, BIOSYNTHESIS, BIOLOGICALACTIVITY AND SYNTHESIS; ABSTRACT; INTRODUCTION; 1. SYNOXAZOLIDINONES A-C; 2. PULMONARINS A AND B; 3. PSAMMAPLYSINS A-Y; 4. CERATINAMIDES A AND B; 5. IANTHELLIFORMISAMINES A-C; 6. WILSONIAMINES A AND B; 7. CONVOLUTAMINES A-J AND LUTAMIDES A, C; 8. AMATHAMIDES A-H; 9. AMATHASPIRAMIDES A-F; 10. KORORAMIDE A AND CONVOLUTINDOLE A; 11. CHARTELLINES A-C AND CHARTELLAMIDES A, B; 12. SECURAMINES A-G AND SECURINES A, B; REFERENCES. Chapter 5: ERYTHRINA ALKALOIDS: RECENT ADVANCES INTHEIR SYNTHESIS, ISOLATION AND PHARMACOLOGYABSTRACT; 1. INTRODUCTION; 2. BOTANICAL ASPECTS OF THE GENUS ERYTHRINA; 3. STRUCTURAL CLASSIFICATION OF ERYTHRINA ALKALOIDS; 4. BIOSYNTHESIS OF ERYTHRINANS; 5. OCCURRENCE AND ISOLATION; 6. SYNTHESIS; 7. PHARMACOLOGY; REFERENCES; Chapter 6: BIOTECHNOLOGICAL APPROACHES FORTHE IMPROVEMENT IN THE PRODUCTIONOF TROPANE ALKALOIDS: IMPLICATIONSAND MEDICINAL APPLICATIONS; ABSTRACT; 1. INTRODUCTION; 2. TROPANE ALKALOIDS; 3. TROPANE ALKALOIDS PRODUCTION; 4 BIOTECHNOLOGICAL STRATEGIES; CONCLUSION; ACKNOWLEDGMENTS.
|
| Abstract
|
:
|
This book discusses a group of natural compounds that is referred to in many bibliographic references for its multiple medical and therapeutic applications, which have been carried out by civilizations in the past and continue to be used in the present. Thus, the alkaloids have been isolated from marine and terrestrial sources and human beings have had the aptitude to determine the chemical structure of many derivatives of simple and big complexity as well as observing the biological effects of every compound in the living organism. Different natural sources as well as the synthesis of many al.
|
| Subject
|
:
|
Alkaloids -- Synthesis.
|
| Subject
|
:
|
Alkaloids -- Therapeutic use.
|
| LC Classification
|
:
|
RM666.A4E383 2015
|
| Added Entry
|
:
|
Eduardo Sobarzo-Sánchez
|
| |